Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rehm

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|August 4, 2023
Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximabYan Felix Karl Dyck, Daniel Rehm, Karsten Winkler, et al.
Bioengineering (Basel, Switzerland)|July 24, 2019
Forced Degradation Testing as Complementary Tool for Biosimilarity AssessmentYan Felix Karl Dyck, Daniel Rehm, Jan Felix Joseph, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Journal of Pharmaceutical and Biomedical Analysis|August 4, 2023
Comparison of middle- and bottom-up mass spectrometry in forced degradation studies of bevacizumab and infliximabYan Felix Karl Dyck, Daniel Rehm, Karsten Winkler, et al.
Bioengineering (Basel, Switzerland)|July 24, 2019
Forced Degradation Testing as Complementary Tool for Biosimilarity AssessmentYan Felix Karl Dyck, Daniel Rehm, Jan Felix Joseph, et al.
Pageof 1